SCHEMBL16629508

SCHEMBL16629508

CN(Cc1ccc(S(C)(=N)=O)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.40
SLC6A4 P31645 1/20 0.40
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
NCOR2 Q9Y618 1/20 0.38
GPR119 Q8TDV5 6/20 0.38
CTSL P07711 1/20 0.37
CTSB P07858 1/20 0.37
CTSS P25774 1/20 0.37
RIPK1 Q13546 2/20 0.37
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MMP13 P45452 2/20 0.35
GLS O94925 1/20 0.35
LIMK2 P53671 1/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17544325 0.84 HDAC3 (0.39) HTR2CSLC6A4HDAC3HDAC1HDAC2
SCHEMBL20681015 0.84 CA2 (0.50) SMN1; SMN2
SCHEMBL2229917 0.82 MTOR (0.48) HTR2CSLC6A4HDAC3HDAC1HDAC2
SCHEMBL23448763 0.81 HRH3 (0.44) HTR2CSLC6A4HDAC3HDAC1HDAC2
SCHEMBL21962676 0.80 HTR2C (0.37) HTR2CSLC6A4HDAC3HDAC1HDAC2
SCHEMBL1109896 0.80 HTR2C (0.37) HTR2CSLC6A4HDAC3HDAC1HDAC2
SCHEMBL25546128 0.79 HSP90AA1 (0.43) HTR2CSLC6A4HDAC3HDAC1HDAC2
SCHEMBL1935308 0.79 PPARG (0.46) HTR2CSLC6A4HDAC3HDAC1HDAC2
SCHEMBL18664587 0.78 MTOR (0.44) HTR2CSLC6A4HDAC3HDAC1HDAC2
SCHEMBL7430459 0.78 RIPK1 (0.59) HTR2CSLC6A4RIPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015050989-A2 MACROCYCLIC COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISEASES CS THERAPEUTICS INC. (US) 2015-04-09 WO disclosed